DEXSTR Unveils Innovative Data Management Tool Inquiro
News Sep 24, 2015
One year after it was created, DEXSTR is among the lead sponsors of the 13th Annual Pharmaceutical IT Congress in London, where it will be presenting Inquiro, the company’s unique solution to manage scientific data. DEXSTR has also announced the backing of IT-Translation, an investor in digital technology start-ups, which is investing €300,000 in this promising young company based in France.
The management of overwhelming quantities of data is one of the key challenges facing life sciences companies today, when an estimated 80% of data generated by research teams remains unstructured. DEXSTR was created by three bioinformatics experts coming from the pharmaceutical industry. They were intent on designing a solution to handle the very large data sets produced by new techniques in biomedical research, such as genomics and next generation sequencing.
“Anyone who has worked in biomedical research has made this frustrating observation: We spend too much time managing, searching and analyzing data. We wanted to build a new application to overcome these challenges, and we wanted to equip researchers with the tools they need” said Erwan David, CTO of DEXSTR.
Inquiro is the Scientific Knowledge Management System (SKMS) developed by DEXSTR. It gathers all unstructured data - from R&D and discovery to pre-clinical data - and allows researchers to store, organize and interconnect such data, facilitating large-scale collaborations among geographically distant research teams. Based on innovative open-sourced technologies, it supports a translational view of research - utilizing data-driven insight and exploiting metadata from the bench to contribute to meaningful health outcomes.
“The success of the translational approach requires business expertise and technical excellence. With our solution and our experience, we can make the most of the knowledge buried in our customers’ R&D data,” said David Peyruc, the company’s CEO.
Analysts highlight that the IT spending of the global life sciences industry will reach $40.8 billion by 2017. It is also estimated that organizations spend $334 million on information management solutions for R&D teams while $100 million is dedicated to Scientific Knowledge Management Systems.
Inquiro is the only system of its kind on the market today, with excellent potential to meet a real need as pharmaceutical companies increasingly invest in IT systems to keep pace with technological innovations and advances in translational informatics.
As of September 21, IT-Translation has invested €300,000 in the capital of DEXSTR within the scope of an ongoing and successful collaboration. IT-Translation has also advised DEXSTR from the company’s inception.
“After four years of existence and the incorporation of 25 start-ups, we know when a company is promising. DEXSTR has definitely all the characteristics of a successful company,” said Laurent Kott, Chairman of the board and co-foundation partner at IT-Translation.
Algorithm Speeds Up Medical Image Analysis 1000 TimesNews
Medical image registration is a common technique that involves overlaying two images, such as magnetic resonance imaging (MRI) scans, to compare and analyze anatomical differences in great detail. Researchers have described a machine-learning algorithm that can register brain scans and other 3-D images more than 1,000 times more quickly using novel learning techniques.
Antarctic Worm and Machine Learning Help Identify Cerebral Palsy EarlierNews
A research team has released a study in the peer-reviewed journal BMC Bioinformatics showing that DNA methylation patterns in circulating blood cells can be used to help identify spastic cerebral palsy (CP) patients. The technique which makes use of machine learning, data science and even analysis of Antarctic worms, raises hopes for earlier targeted CP therapies.
Towards Personalized Medicine: One Type of Data is Not EnoughNews
To understand the biology of diseased organs researchers use different types of molecular data. One of the biggest computational challenges at the moment is integrating these multiple data types. A new computational method jointly analyses different types of molecular data and disentangles the sources of disease variability to guide personalized treatment.READ MORE